Enzo Biochem Inc Net Income per Employee (ENZ), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Enzo Biochem Inc  (NYSE: ENZ)
 

Enzo Biochem Inc Net Income per Employee

ENZ's Quarterly Results, Trends, Rankings, Statistics
Enzo Biochem Inc recorded a cumulative net loss of $-21 million during 12 month ending in the third quarter 2025.
The Healthcare sector has seen employees of 26 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 3075, from total ranking in previous quarter at 3170.


What is Income per Employee Ratio?






ENZ Net Income per Employee (Apr 30 2025)
III. Quarter
(Jan 31 2025)
II. Quarter
(Oct 31 2024)
I. Quarter
(Jul 31 2024)
IV. Quarter
(Apr 30 2024)
III. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -52,574 -53,147 -56,953 -65,032 111,554
ENZ's Total Ranking # 3075 # 3170 # 785 # 1155 # 1230
Seq. Net Income Change - - - - -


ENZ Net Income per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 27
Healthcare Sector # 289
Overall Market # 3075

Net Income per Employee Statistics
High Average Low
$ 112,933 $ -15,667 $ -116,638
(Jul 31 2016)   (Apr 30 2013)







Companies with similar Income per Employee for 12 month ending Apr 30 2025, within Healthcare Sector Income per Employee Income 12 month ending Apr 30 2025Number of Employees Apr 30 2025


Date modified: 2026-09-08T17:35:01+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.